30-Day Hospitalization Period for Pituitary Adenoma Patients: Introducing A Novel Outcome Metric
Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398
DOI: 10.1055/s-0044-1779930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Anthony Tang und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Pituitary adenomas are among the most common central nervous system tumors in adults representing 10–15% of all intracranial tumors. A variety of qualitative and quantitative metrics are used to assess surgical outcomes. A novel metric was developed that incorporates both length of stay and readmission in one metric, the 30-day hospitalization ratio (HR) (total number of days of hospitalization/30 days). The goals for this study were to determine predictive factors associated with prolonged patient and hospital economic burden and to demonstrate the utility of 30-day HR as a novel outcome metric compared to LOS and readmission.
Methods
The clinical records of 492 patients who underwent an endoscopic endonasal approach (EEA) for pituitary adenoma at a pituitary Center of Excellence between January 2015 and September 2022 were reviewed. 468 patients met all criteria including: (1) EEA surgery for pituitary adenoma, (2) minimum postoperative follow-up of one month at UPMC, and (3) no postoperative surgical intervention (i.e., cerebrospinal fluid leak repair, residual tumor removal). Variables collected include functional vs. nonfunctional, primary vs. recurrent, BMI, age, sex, risk assessment index (RAI), surgical approach, intraoperative leak, lumbar drain placement, nasoseptal flap, length of stay (LOS), readmission, and 30-day. High HR was defined as HR >13% (top 25th percentile). Univariate analysis was done using chi-square and t-tests. Multivariate logistic regression modeling was completed, entering into the model variables that were associated with high HR and other clinically relevant variables from univariate analysis. An α = 0.05 was used to determine statistical significance.
Results
The 468 patients had an average age of 55.4 ± 16.5 years; there were slightly more males (53.8%) and patients were predominantly white (82.5%). 49.2% of patients were employed, 6.2% were unemployed, 23.7% were retired, 5.3% were disabled, and 15.6% had unknown employment status. Patients that were unemployed, retired, or disabled were grouped as not-employed status. The average BMI was 31.2 ± 7.1. Univariate analysis found an ASA score of 3 or 4 ( p = 0.012), additional extrasellar approaches ( p = 0.012), nasoseptal flap reconstruction ( p = 0.003), intra-operative lumbar drain placement ( p < 0.001), discharge to rehab ( p < 0.001), and not-employed status ( p = 0.006) to be significantly correlated with a high HR. Logistical regression modeling for high HR found an ASA score of 3 or 4 (vs. 1, 2) (OR = 2.29, [1.02, 5.11], p = 0.044), intra-operative lumbar drain placement (OR = 14.29, [2.75, 74.41], p = 0.002), p < 0.001), and not-employed status (OR = 0.37, [0.20, 0.71], p = 0.002) to be associated with a high HR.
Conclusions
The 30-day HR metric is a novel quantitative measurement that combines surgery LOS and readmission to provide a more complete quantification of the economic burden from treatment. High-risk factors for increased HR included high preoperative ASA scores, postoperative lumbar drain placement, intradural extension, and employment status. Understanding risk factors for increased posttreatment patient and hospital burden can lead to more personalized monitoring and care, leading to reduced burden and improved outcomes after treatment. Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Tang, A., Abdallah, H. M., Gardner, P., Zenonos, G. A., Chang, Y., Choby, G., Wang, E. W., & Snyderman, C. (2024). 30-Day Hospitalization Period for Pituitary Adenoma Patients: Introducing A Novel Outcome Metric. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779930
Vancouver
Tang A, Abdallah HM, Gardner P, Zenonos GA, Chang Y, Choby G, et al. 30-Day Hospitalization Period for Pituitary Adenoma Patients: Introducing A Novel Outcome Metric. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779930
BibTeX
@article{Tang2024,
author = {Tang, Anthony and Abdallah, Hussein M. and Gardner, Paul and Zenonos, Georgios A. and Chang, Yue-Fang and Choby, Garret and Wang, Eric W. and Snyderman, Carl},
title = {30-Day Hospitalization Period for Pituitary Adenoma Patients: Introducing A Novel Outcome Metric},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {S 01 S 01},
pages = {S1--S398},
doi = {10.1055/s-0044-1779930}
}
EUVIMED